Breaking News Instant updates and real-time market news.

AERI

Aerie Pharmaceuticals

$38.85

-0.64 (-1.62%)

06:49
04/25/19
04/25
06:49
04/25/19
06:49

Aerie Pharmaceuticals: NDA for AR-13503 accepted by FDA

Aerie Pharmaceuticals announced that the U.S. FDA has reviewed the Investigational New Drug Application for AR-13503 and it is now in effect, allowing Aerie to initiate human studies in the treatment of neovascular age-related macular degeneration and diabetic macular edema. The IND was submitted in March. Aerie expects to initiate a first-in-human clinical study later in the second quarter.

  • 28

    Apr

  • 23

    May

AERI Aerie Pharmaceuticals
$38.85

-0.64 (-1.62%)

03/05/19
ADAM
03/05/19
NO CHANGE
Target $73
ADAM
Buy
Aerie Pharmaceuticals price target lowered to $73 from $86 at Canaccord
Canaccord analyst Dewey Steadman lowered his price target on Aerie Pharmaceuticals to $73 from $86 as Rhopressa data for the week ending February 22 showed mixed growth as very modest TRx growth did not translate into sequential bottle dispensing growth. The analyst said Rhopressa has been stuck on a plateau for the past few weeks and there needs to be a meaningful acceleration of dispensing for the company to meet expectations. Steadman maintained his Buy rating on Aerie Pharmaceuticals shares.
03/13/19
JMPS
03/13/19
NO CHANGE
Target $75
JMPS
Outperform
JMP Securities sees fast adoption for Aerie Pharmaceuticals' Rocklatan
After Aerie Pharmaceuticals announced that it received early FDA approval of Rocklatan, JMP Securities analyst Donald Ellis said he expects the drug to be quickly adopted by physicians and patients given its best-in-class efficacy and once-a-day dosing. Many physicians are already prescribing Rhopressa + PGA and he would expect many to switch to Rocklatan alone, added Ellis, who keeps an Outperform rating and $75 price target on Aerie shares.
03/19/19
ADAM
03/19/19
NO CHANGE
Target $65
ADAM
Buy
Aerie Pharmaceuticals price target cut to $65 from $73 at Canaccord
Canaccord analyst Dewey Steadman maintained a Buy rating on Aerie Pharmaceuticals and cut his price target to $65 from $73 after weekly Rhopressa data showed modest sequentially growth for the week ending March 8 after a strong prior week. In a research note to investors, Steadman says 10 weeks into the quarter, he is bringing down revenue estimates below consensus as he thinks volumes don't justify a $17M+ revenue estimate for the quarter.
03/21/19
PIPR
03/21/19
INITIATION
Target $80
PIPR
Overweight
Aerie Pharmaceuticals initiated with an Overweight at Piper Jaffray
Piper Jaffray analyst Joseph Catanzaro started Aerie Pharmaceuticals with an Overweight rating and $80 price target. Rhopressa is off to a "nice start" in its first few quarters, and key opinion leader feedback indicates the recently approved Rocklatan has the potential to transform the glaucoma treatment landscape in the U.S., Catanzaro tells investors in a research note. He believes Aerie's glaucoma franchise has the potential to generate U.S. sales in excess of $800M by 2025 and expects the shares to appreciate as this revenue opportunity is realized.

TODAY'S FREE FLY STORIES

ACAD

Acadia

$25.97

0.28 (1.09%)

16:35
07/22/19
07/22
16:35
07/22/19
16:35
Hot Stocks
Breaking Hot Stocks news story on Acadia 

Acadia trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 20

    Aug

FULC

Fulcrum Therapeutics

$12.84

0.35 (2.80%)

16:34
07/22/19
07/22
16:34
07/22/19
16:34
Hot Stocks
Fulcrum Therapeutics chairman Mark Levin buys $1.3M in company shares »

Fulcrum Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$105.66

-1.35 (-1.26%)

16:34
07/22/19
07/22
16:34
07/22/19
16:34
Earnings
Celanese still sees 'path to' FY19 EPS of $10.50, consensus $10.20 »

CEO Lori Ryerkerk says:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

FTI

TechnipFMC

$25.61

0.5 (1.99%)

16:33
07/22/19
07/22
16:33
07/22/19
16:33
Hot Stocks
TechnipFMC awarded iEPCI contract from Neptune Energy for Seagull project »

TechnipFMC has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 27

    Aug

CE

Celanese

$105.66

-1.35 (-1.26%)

16:33
07/22/19
07/22
16:33
07/22/19
16:33
Hot Stocks
Celanese reports Q2 operating EBITDA $458M vs. $573M last year »

Reports Q2 free cash flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

CTST

CannTrust

$2.73

-0.04 (-1.44%)

16:32
07/22/19
07/22
16:32
07/22/19
16:32
Hot Stocks
CannTrust agrees to waive exclusivity provision under agreement with Kindred »

CannTrust Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVCO

Avalon GloboCare

$2.05

-0.105 (-4.88%)

, GE

General Electric

$10.22

0.18 (1.79%)

16:31
07/22/19
07/22
16:31
07/22/19
16:31
Hot Stocks
Avalon GloboCare, GE Healthcare announce strategic partnership »

Avalon GloboCare (AVCO)…

AVCO

Avalon GloboCare

$2.05

-0.105 (-4.88%)

GE

General Electric

$10.22

0.18 (1.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 09

    Sep

  • 09

    Sep

CE

Celanese

$105.66

-1.35 (-1.26%)

16:31
07/22/19
07/22
16:31
07/22/19
16:31
Earnings
Celanese reports Q2 adjusted EPS $2.38, consensus $2.35 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

NBTB

NBT Bancorp

$37.09

-0.15 (-0.40%)

16:30
07/22/19
07/22
16:30
07/22/19
16:30
Earnings
NBT Bancorp reports Q2 EPS 69c, consensus 66c »

Reports Q2 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WSFS

WSFS Financial

$39.25

-0.5 (-1.26%)

16:30
07/22/19
07/22
16:30
07/22/19
16:30
Earnings
WSFS Financial reports Q2 core EPS 88c, consensus 74c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 23

    Sep

ASR

Asur

$159.99

-2.945 (-1.81%)

16:30
07/22/19
07/22
16:30
07/22/19
16:30
Hot Stocks
Asur reports Q2 passenger traffic up 6.9% over last year »

Grupo Aeroportuario del…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

16:30
07/22/19
07/22
16:30
07/22/19
16:30
Options
Preliminary option volume of 14.3M today »

Preliminary option volume…

TBIO

Translate Bio

$9.61

0.26 (2.78%)

16:27
07/22/19
07/22
16:27
07/22/19
16:27
Syndicate
Translate Bio enters $50M open market common stock sales agreement »

Jefferes will be acting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHMG

Chemung Financial

$47.90

0.14 (0.29%)

16:26
07/22/19
07/22
16:26
07/22/19
16:26
Earnings
Chemung Financial reports Q2 EPS $1.02, one estimate $1.01 »

Net interest income for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIVE

Viveve

$0.41

-0.0155 (-3.68%)

16:25
07/22/19
07/22
16:25
07/22/19
16:25
Hot Stocks
Breaking Hot Stocks news story on Viveve »

Viveve trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RBB

RBB Bancorp

$19.14

-0.23 (-1.19%)

16:24
07/22/19
07/22
16:24
07/22/19
16:24
Earnings
RBB Bancorp reports Q2 EPS 50c, consensus 51c »

Net interest margin was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 23

    Sep

BLMN

Bloomin' Brands

$17.48

-0.37 (-2.07%)

16:24
07/22/19
07/22
16:24
07/22/19
16:24
Initiation
Bloomin' Brands initiated  »

Bloomin' Brands…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

BA

Boeing

$373.39

-3.95 (-1.05%)

16:22
07/22/19
07/22
16:22
07/22/19
16:22
Hot Stocks
Moody's affirms Boeing's A2 senior unsecured rating, changes outlook to negative »

Moody's Investors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

TWTR

Twitter

$37.58

0.81 (2.20%)

16:22
07/22/19
07/22
16:22
07/22/19
16:22
Initiation
Twitter initiated at Rosenblatt »

Twitter initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 30

    Jul

BCEI

Bonanza Creek

$21.39

0.12 (0.56%)

16:22
07/22/19
07/22
16:22
07/22/19
16:22
Hot Stocks
Bonanza Creek reports preliminary Q2 sales volume 24.4 MBoepd »

Reports preliminary Q2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDN

Brandywine Realty

$14.32

-0.04 (-0.28%)

16:22
07/22/19
07/22
16:22
07/22/19
16:22
Earnings
Brandywine Realty sees FY19 FFO $1.40-$1.44 »

We have made excellent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

BDN

Brandywine Realty

$14.32

-0.04 (-0.28%)

16:21
07/22/19
07/22
16:21
07/22/19
16:21
Earnings
Brandywine Realty reports Q2 FFO 35c, consensus 36c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

ACC

American Campus

$48.06

0.275 (0.58%)

16:20
07/22/19
07/22
16:20
07/22/19
16:20
Earnings
American Campus backs FY19 FFOM view $2.35-$2.45, consensus $2.42 »

The company is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

UNIT

Uniti Group

$8.50

0.13 (1.55%)

16:20
07/22/19
07/22
16:20
07/22/19
16:20
Hot Stocks
Uniti Group responds to motion filed by Windstream seeking mediator »

Uniti Group issued a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

ACC

American Campus

$48.06

0.275 (0.58%)

16:20
07/22/19
07/22
16:20
07/22/19
16:20
Earnings
American Campus Communities reports Q2 FFOM 56c, consensus 54c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.